ATE110568T1 - Pharmazeutisches präparat zur behandlung des katarakts. - Google Patents
Pharmazeutisches präparat zur behandlung des katarakts.Info
- Publication number
- ATE110568T1 ATE110568T1 AT87117637T AT87117637T ATE110568T1 AT E110568 T1 ATE110568 T1 AT E110568T1 AT 87117637 T AT87117637 T AT 87117637T AT 87117637 T AT87117637 T AT 87117637T AT E110568 T1 ATE110568 T1 AT E110568T1
- Authority
- AT
- Austria
- Prior art keywords
- cataract
- treatment
- pharmaceutical preparation
- compound
- remedies
- Prior art date
Links
- 208000002177 Cataract Diseases 0.000 title abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28807686 | 1986-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE110568T1 true ATE110568T1 (de) | 1994-09-15 |
Family
ID=17725491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87117637T ATE110568T1 (de) | 1986-12-03 | 1987-11-28 | Pharmazeutisches präparat zur behandlung des katarakts. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4826872A (de) |
| EP (1) | EP0270046B1 (de) |
| KR (1) | KR950007099B1 (de) |
| CN (1) | CN1016313B (de) |
| AT (1) | ATE110568T1 (de) |
| CA (1) | CA1300504C (de) |
| DE (1) | DE3750464T2 (de) |
| ES (1) | ES2059348T3 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871350A (en) * | 1986-11-04 | 1989-10-03 | Baylor College Of Medicine | Methods and compositions for preventing secondary cataracts |
| US4966577A (en) * | 1988-03-16 | 1990-10-30 | Allergan, Inc. | Prevention of lens-related tissue growth in the eye |
| US5627162A (en) * | 1990-01-11 | 1997-05-06 | Gwon; Arlene E. | Methods and means for control of proliferation of remnant cells following surgery |
| US6046019A (en) * | 1991-07-09 | 2000-04-04 | Goumeniouk; Alexander P. | Diagnostic kits and methods for making granulocyte cell counts |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| EP1099440A4 (de) | 1998-06-26 | 2005-01-19 | Takara Bio Inc | Therapeutische mittel |
| EP1358883B8 (de) * | 2002-04-30 | 2007-10-03 | Sifi S.p.A | Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen |
| US20040229814A1 (en) * | 2002-08-28 | 2004-11-18 | James Dillon | Methods and compositions for protecting against cataract development associated with vitrectomies |
| US20070166402A1 (en) * | 2005-12-12 | 2007-07-19 | Friedlaender Mitchell H | Compositions, methods and kits for removing debris from an ocular area |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤,アスコルビン酸誘導体およびその製造法 |
| EP0189272A3 (de) * | 1985-01-17 | 1987-08-19 | Fujisawa Pharmaceutical Co., Ltd. | Furanonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| ZA852614B (en) * | 1985-05-17 | 1986-10-09 | Takeda Chemical Industries, Ltd. | Ascorbic acid ethers and their production |
-
1987
- 1987-11-17 US US07/121,919 patent/US4826872A/en not_active Expired - Fee Related
- 1987-11-28 DE DE3750464T patent/DE3750464T2/de not_active Expired - Fee Related
- 1987-11-28 EP EP87117637A patent/EP0270046B1/de not_active Expired - Lifetime
- 1987-11-28 AT AT87117637T patent/ATE110568T1/de not_active IP Right Cessation
- 1987-11-28 ES ES87117637T patent/ES2059348T3/es not_active Expired - Lifetime
- 1987-12-02 CN CN87107231A patent/CN1016313B/zh not_active Expired
- 1987-12-02 KR KR1019870013736A patent/KR950007099B1/ko not_active Expired - Fee Related
- 1987-12-02 CA CA000553319A patent/CA1300504C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR950007099B1 (ko) | 1995-06-30 |
| EP0270046A3 (en) | 1990-06-13 |
| CN1016313B (zh) | 1992-04-22 |
| DE3750464T2 (de) | 1995-02-09 |
| US4826872A (en) | 1989-05-02 |
| CA1300504C (en) | 1992-05-12 |
| EP0270046B1 (de) | 1994-08-31 |
| KR880007070A (ko) | 1988-08-26 |
| EP0270046A2 (de) | 1988-06-08 |
| ES2059348T3 (es) | 1994-11-16 |
| DE3750464D1 (de) | 1994-10-06 |
| CN87107231A (zh) | 1988-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| SE8604566D0 (sv) | Novel compunds | |
| EP0255728A3 (en) | Phenoxyacetic acid compounds, their preparation, pharmaceutical composition and use | |
| ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
| ATE110568T1 (de) | Pharmazeutisches präparat zur behandlung des katarakts. | |
| SE8600658D0 (sv) | Novel composition of matter | |
| SG39892G (en) | 4,5-dihydro-oxazole derivatives,process for their preparation and their use | |
| ATE38982T1 (de) | Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel. | |
| ATE92315T1 (de) | Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate. | |
| HUT41025A (en) | Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| DE3884878D1 (de) | Uricosuretische Zusammensetzung. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| ATE32514T1 (de) | 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE3784883D1 (de) | Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln. | |
| PH22441A (en) | Quinate salts of the antimaterial compound mefloquine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |